Corrigendum to “Pegylated Ofloxacin Nanoparticles Render Strong Antibacterial Activity Against Many Clinically Important Human Pathogens” (Colloids and Surfaces B: Biointerfaces (2015) 132 (62–70), (S0927776515002696) (10.1016/J.colsurfb.2015.04.050))